Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the coronavirus disease (COVID-19) pandemic, has infected millions of people globally. Genetic variation and selective pressures lead to the accumulation of single nucleotide polymorphism (SNP) within the viral genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghorbani, Abozar, Samarfard, Samira, Jajarmi, Maziar, Bagheri, Mahboube, Karbanowicz, Thomas P., Afsharifar, Alireza, Eskandari, Mohammad Hadi, Niazi, Ali, Izadpanah, Keramatollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808475/
https://www.ncbi.nlm.nih.gov/pubmed/35128175
http://dx.doi.org/10.1016/j.genrep.2022.101537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808475/
https://www.ncbi.nlm.nih.gov/pubmed/35128175
http://dx.doi.org/10.1016/j.genrep.2022.101537

Ejemplares similares